Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J Kullberg

Showing results (11-20 of 165) with videos related to

Pageof 17
Sort By:
Biotherapy (Dordrecht, Netherlands)|January 1, 1994
Introduction: cytokines in the biotherapy of infectious diseasesB J Kullberg, J W van der Meer
Nederlands Tijdschrift Voor Geneeskunde|September 30, 2004
[Amphotericin B: the end of an era]A M L Oude Lashof, B J Kullberg
Nederlands Tijdschrift Voor Geneeskunde|November 5, 1994
[Infections during intensive care: a vicious circle]J W van der Meer, B J Kullberg
European Journal of Medical Research|June 19, 2002
Epidemiology of opportunistic invasive mycosesB J Kullberg, A M L Oude Lashof
Nederlands Tijdschrift Voor Geneeskunde|December 29, 2007
[Invasive zygomycosis: notably in diabetes mellitus and iron overload]B J Kullberg, J W van 't Wout
Nederlands Tijdschrift Voor Geneeskunde|July 15, 1995
[Treatment and prevention of generalized mycoses]B J Kullberg, J W van 't Wout
Nederlands Tijdschrift Voor Geneeskunde|December 21, 1996
[Clinical judgement and decision making in clinical practice. A patient with fever and neck pain]J W van der Meer, B J Kullberg
Biotherapy (Dordrecht, Netherlands)|January 1, 1994
Cytokines in the treatment of fungal infectionsB J Kullberg, J W van 't Wout
The Netherlands Journal of Medicine|September 28, 2005
National guidelines for the use of antibiotics in hospitalised adult patients: the SWAB guidelines revisitedJ M Prins, B J Kullberg, I C Gyssens
Nederlands Tijdschrift Voor Geneeskunde|March 22, 2001
[Optimizing antibiotics policy in the Netherlands. VI. SWAB advice: no selective decontamination of intensive care patients on mechanical ventilation]M J Bonten, B J Kullberg, P M Filius, et al.
Pageof 17

Showing results (11-20 of 165) with videos related to

Sort By:
Pageof 17
Biotherapy (Dordrecht, Netherlands)|January 1, 1994
Introduction: cytokines in the biotherapy of infectious diseasesB J Kullberg, J W van der Meer
Nederlands Tijdschrift Voor Geneeskunde|September 30, 2004
[Amphotericin B: the end of an era]A M L Oude Lashof, B J Kullberg
Nederlands Tijdschrift Voor Geneeskunde|November 5, 1994
[Infections during intensive care: a vicious circle]J W van der Meer, B J Kullberg
European Journal of Medical Research|June 19, 2002
Epidemiology of opportunistic invasive mycosesB J Kullberg, A M L Oude Lashof
Nederlands Tijdschrift Voor Geneeskunde|December 29, 2007
[Invasive zygomycosis: notably in diabetes mellitus and iron overload]B J Kullberg, J W van 't Wout
Nederlands Tijdschrift Voor Geneeskunde|July 15, 1995
[Treatment and prevention of generalized mycoses]B J Kullberg, J W van 't Wout
Nederlands Tijdschrift Voor Geneeskunde|December 21, 1996
[Clinical judgement and decision making in clinical practice. A patient with fever and neck pain]J W van der Meer, B J Kullberg
Biotherapy (Dordrecht, Netherlands)|January 1, 1994
Cytokines in the treatment of fungal infectionsB J Kullberg, J W van 't Wout
The Netherlands Journal of Medicine|September 28, 2005
National guidelines for the use of antibiotics in hospitalised adult patients: the SWAB guidelines revisitedJ M Prins, B J Kullberg, I C Gyssens
Nederlands Tijdschrift Voor Geneeskunde|March 22, 2001
[Optimizing antibiotics policy in the Netherlands. VI. SWAB advice: no selective decontamination of intensive care patients on mechanical ventilation]M J Bonten, B J Kullberg, P M Filius, et al.
Pageof 17